Positron emission tomography radiotracers for imaging hypoxia
Authors:
- 1 March 2013
- journal article
- review article
- Published by Wiley in Journal of Labelled Compounds and Radiopharmaceuticals
- Vol. 56 (3-4) , 244-250
Abstract
Localized hypoxia, the physiological hallmark of many clinical pathologies, is the consequence of acute or chronic ischemia in the affected region or tissue. The versatility, sensitivity, quantitative nature, and increasing availability of positron emission tomography (PET) make it the preclinical and clinical method of choice for functional imaging of tissue hypoxia at the molecular level. The progress and current status of radiotracers for hypoxia‐specific PET imaging are reviewed in this article including references mainly focused on radiochemistry and also relevant to molecular imaging of hypoxia in preclinical and clinical studies.Keywords
This publication has 54 references indexed in Scilit:
- A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[18F]pentafluoropropyl)-acetamide ([18F]EF5)Nuclear Medicine and Biology, 2012
- Preclinical evaluation and validation of [ 18 F]HX4, a promising hypoxia marker for PET imagingProceedings of the National Academy of Sciences, 2011
- Synthesis and evaluation of two novel 2-nitroimidazole derivatives as potential PET radioligands for tumor imagingNuclear Medicine and Biology, 2011
- Synthesis of hypoxia imaging agent 1-(5-deoxy-5-fluoro-α-d-arabinofuranosyl)-2-nitroimidazole using microfluidic technologyNuclear Medicine and Biology, 2011
- Biodistribution and radiation dosimetry of the hypoxia marker 18F–HX4 in monkeys and humans determined by using whole-body PET/CTNuclear Medicine Communications, 2010
- Biodistribution and dosimetry of 18F-EF5 in cancer patients with preliminary comparison of 18F-EF5 uptake versus EF5 binding in human glioblastomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- PET imaging of hypoxia using [18F]HX4: a phase I trialEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Copper-64 Radiopharmaceuticals for PET Imaging of Cancer: Advances in Preclinical and Clinical ResearchCancer Biotherapy and Radiopharmaceuticals, 2009
- Molecular imaging of hypoxia with radiolabelled agentsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Fully automated one-pot synthesis of [18F]fluoromisonidazoleNuclear Medicine and Biology, 2005